Global Artificial Intelligence Drug R&D Market Growth (Status and Outlook) 2026-2032
The global Artificial Intelligence Drug R&D market size is predicted to grow from US$ 714 million in 2025 to US$ 1295 million in 2032; it is expected to grow at a CAGR of 8.4% from 2026 to 2032.
Artificial Intelligence Drug R&D (AI Drug Development) refers to a class of R&D methods and software/platform systems that utilize technologies such as machine learning, deep learning, generative models, and knowledge graphs to model and infer multi-omics and biomedical data throughout the entire drug development process, from target discovery to lead compounds, preclinical trials, clinical trials, and post-marketing. This aims to improve the accuracy of target selection, shorten the candidate drug discovery cycle, reduce the failure rate, and optimize trial design and patient stratification.
AI-driven drug development is transitioning from 'proof of concept' to 'deliverable productivity.' On one hand, large pharmaceutical companies and platform companies are emphasizing interpretability, auditability, and compliance (GxP/data governance), embedding AI models into existing experimental automation, LIMS/ELN, cheminformatics, and clinical operations systems to form an 'AI + experimental closed loop' (design–make–test–analyze). On the other hand, industry focus is shifting from single-point tools to end-to-end capabilities: for example, integrating target selection, molecular generation, ADMET, and clinical strategies, while enhancing model generalization capabilities through multimodal data (omics, imaging, EHR, literature, and patents), making AI more closely aligned with real-world R&D decisions.
Simultaneously, generative AI is reshaping the workflow of early-stage research and translational medicine: at the molecular and protein level, the combination of generation and screening (virtual screening + de novo design) is becoming more common; at the clinical level, real-world data and patient stratification are driving 'more precise enrollment and endpoint selection' to reduce trial size or increase success rates. In terms of commercialization, the cooperation model has expanded from 'software subscription' to 'milestone/revenue sharing, joint R&D, and joint pipeline incubation', and places greater emphasis on quantifiable deliverables (hit rate, shortened cycle, candidate quality) and reproducible verification system.
LPI (LP Information)' newest research report, the “Artificial Intelligence Drug R&D Industry Forecast” looks at past sales and reviews total world Artificial Intelligence Drug R&D sales in 2025, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence Drug R&D sales for 2026 through 2032. With Artificial Intelligence Drug R&D sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence Drug R&D industry.
This Insight Report provides a comprehensive analysis of the global Artificial Intelligence Drug R&D landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Artificial Intelligence Drug R&D portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Intelligence Drug R&D market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence Drug R&D and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence Drug R&D.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence Drug R&D market by product type, application, key players and key regions and countries.
Segmentation by Type:
Artificial Intelligence Drug R&D (AI Drug Development) refers to a class of R&D methods and software/platform systems that utilize technologies such as machine learning, deep learning, generative models, and knowledge graphs to model and infer multi-omics and biomedical data throughout the entire drug development process, from target discovery to lead compounds, preclinical trials, clinical trials, and post-marketing. This aims to improve the accuracy of target selection, shorten the candidate drug discovery cycle, reduce the failure rate, and optimize trial design and patient stratification.
AI-driven drug development is transitioning from 'proof of concept' to 'deliverable productivity.' On one hand, large pharmaceutical companies and platform companies are emphasizing interpretability, auditability, and compliance (GxP/data governance), embedding AI models into existing experimental automation, LIMS/ELN, cheminformatics, and clinical operations systems to form an 'AI + experimental closed loop' (design–make–test–analyze). On the other hand, industry focus is shifting from single-point tools to end-to-end capabilities: for example, integrating target selection, molecular generation, ADMET, and clinical strategies, while enhancing model generalization capabilities through multimodal data (omics, imaging, EHR, literature, and patents), making AI more closely aligned with real-world R&D decisions.
Simultaneously, generative AI is reshaping the workflow of early-stage research and translational medicine: at the molecular and protein level, the combination of generation and screening (virtual screening + de novo design) is becoming more common; at the clinical level, real-world data and patient stratification are driving 'more precise enrollment and endpoint selection' to reduce trial size or increase success rates. In terms of commercialization, the cooperation model has expanded from 'software subscription' to 'milestone/revenue sharing, joint R&D, and joint pipeline incubation', and places greater emphasis on quantifiable deliverables (hit rate, shortened cycle, candidate quality) and reproducible verification system.
LPI (LP Information)' newest research report, the “Artificial Intelligence Drug R&D Industry Forecast” looks at past sales and reviews total world Artificial Intelligence Drug R&D sales in 2025, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence Drug R&D sales for 2026 through 2032. With Artificial Intelligence Drug R&D sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence Drug R&D industry.
This Insight Report provides a comprehensive analysis of the global Artificial Intelligence Drug R&D landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Artificial Intelligence Drug R&D portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Intelligence Drug R&D market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence Drug R&D and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence Drug R&D.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence Drug R&D market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Software
- Service
- Target Identification & Validation
- Hit/Lead Discovery
- Clinical Development & Trial Design
- Others
- Machine Learning & Deep Learning
- Generative Models
- Knowledge Graph & NLP
- Multi-omics / Multimodal Modeling
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations?CRO)
- Academic & Research Institutions
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Insilico Medicine
- Recursion
- BenevolentAI
- Atomwise
- Recursion Pharmaceuticals
- DeepMind?Google?
- Insitro
- Owkin
- XtalPi
- Verge Genomics
- Iktos
- Valo Health
- Standigm
- Relay Therapeutics
- Cyclica
- Isomorphic Labs
- Schr?dinger
- Absci
- Genesis Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Intelligence Drug R&D Market Size (2021-2032)
2.1.2 Artificial Intelligence Drug R&D Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Artificial Intelligence Drug R&D by Country/Region (2021, 2025 & 2032)
2.2 Artificial Intelligence Drug R&D Segment by Type
2.2.1 Software
2.2.2 Service
2.2.3 Artificial Intelligence Drug R&D Market Size by Type
2.2.3.1 Artificial Intelligence Drug R&D Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
2.3 Artificial Intelligence Drug R&D Segment by Stage
2.3.1 Target Identification & Validation
2.3.2 Hit/Lead Discovery
2.3.3 Clinical Development & Trial Design
2.3.4 Others
2.3.5 Artificial Intelligence Drug R&D Market Size by Stage
2.3.5.1 Artificial Intelligence Drug R&D Market Size CAGR by Stage (2021 VS 2025 VS 2032)
2.3.5.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Stage (2021-2026)
2.4 Artificial Intelligence Drug R&D Segment by Technology
2.4.1 Machine Learning & Deep Learning
2.4.2 Generative Models
2.4.3 Knowledge Graph & NLP
2.4.4 Multi-omics / Multimodal Modeling
2.4.5 Artificial Intelligence Drug R&D Market Size by Technology
2.4.5.1 Artificial Intelligence Drug R&D Market Size CAGR by Technology (2021 VS 2025 VS 2032)
2.4.5.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Technology (2021-2026)
2.5 Artificial Intelligence Drug R&D Segment by Application
2.5.1 Pharmaceutical Companies
2.5.2 Biotechnology Companies
2.5.3 Contract Research Organizations?CRO)
2.5.4 Academic & Research Institutions
2.5.5 Others
2.5.6 Artificial Intelligence Drug R&D Market Size by Application
2.5.6.1 Artificial Intelligence Drug R&D Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.6.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)
3 ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE BY PLAYER
3.1 Artificial Intelligence Drug R&D Market Size Market Share by Player
3.1.1 Global Artificial Intelligence Drug R&D Revenue by Player (2021-2026)
3.1.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Player (2021-2026)
3.2 Global Artificial Intelligence Drug R&D Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ARTIFICIAL INTELLIGENCE DRUG R&D BY REGION
4.1 Artificial Intelligence Drug R&D Market Size by Region (2021-2026)
4.2 Global Artificial Intelligence Drug R&D Annual Revenue by Country/Region (2021-2026)
4.3 Americas Artificial Intelligence Drug R&D Market Size Growth (2021-2026)
4.4 APAC Artificial Intelligence Drug R&D Market Size Growth (2021-2026)
4.5 Europe Artificial Intelligence Drug R&D Market Size Growth (2021-2026)
4.6 Middle East & Africa Artificial Intelligence Drug R&D Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Artificial Intelligence Drug R&D Market Size by Country (2021-2026)
5.2 Americas Artificial Intelligence Drug R&D Market Size by Type (2021-2026)
5.3 Americas Artificial Intelligence Drug R&D Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence Drug R&D Market Size by Region (2021-2026)
6.2 APAC Artificial Intelligence Drug R&D Market Size by Type (2021-2026)
6.3 APAC Artificial Intelligence Drug R&D Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Artificial Intelligence Drug R&D Market Size by Country (2021-2026)
7.2 Europe Artificial Intelligence Drug R&D Market Size by Type (2021-2026)
7.3 Europe Artificial Intelligence Drug R&D Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Intelligence Drug R&D by Region (2021-2026)
8.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2021-2026)
8.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ARTIFICIAL INTELLIGENCE DRUG R&D MARKET FORECAST
10.1 Global Artificial Intelligence Drug R&D Forecast by Region (2027-2032)
10.1.1 Global Artificial Intelligence Drug R&D Forecast by Region (2027-2032)
10.1.2 Americas Artificial Intelligence Drug R&D Forecast
10.1.3 APAC Artificial Intelligence Drug R&D Forecast
10.1.4 Europe Artificial Intelligence Drug R&D Forecast
10.1.5 Middle East & Africa Artificial Intelligence Drug R&D Forecast
10.2 Americas Artificial Intelligence Drug R&D Forecast by Country (2027-2032)
10.2.1 United States Market Artificial Intelligence Drug R&D Forecast
10.2.2 Canada Market Artificial Intelligence Drug R&D Forecast
10.2.3 Mexico Market Artificial Intelligence Drug R&D Forecast
10.2.4 Brazil Market Artificial Intelligence Drug R&D Forecast
10.3 APAC Artificial Intelligence Drug R&D Forecast by Region (2027-2032)
10.3.1 China Artificial Intelligence Drug R&D Market Forecast
10.3.2 Japan Market Artificial Intelligence Drug R&D Forecast
10.3.3 Korea Market Artificial Intelligence Drug R&D Forecast
10.3.4 Southeast Asia Market Artificial Intelligence Drug R&D Forecast
10.3.5 India Market Artificial Intelligence Drug R&D Forecast
10.3.6 Australia Market Artificial Intelligence Drug R&D Forecast
10.4 Europe Artificial Intelligence Drug R&D Forecast by Country (2027-2032)
10.4.1 Germany Market Artificial Intelligence Drug R&D Forecast
10.4.2 France Market Artificial Intelligence Drug R&D Forecast
10.4.3 UK Market Artificial Intelligence Drug R&D Forecast
10.4.4 Italy Market Artificial Intelligence Drug R&D Forecast
10.4.5 Russia Market Artificial Intelligence Drug R&D Forecast
10.5 Middle East & Africa Artificial Intelligence Drug R&D Forecast by Region (2027-2032)
10.5.1 Egypt Market Artificial Intelligence Drug R&D Forecast
10.5.2 South Africa Market Artificial Intelligence Drug R&D Forecast
10.5.3 Israel Market Artificial Intelligence Drug R&D Forecast
10.5.4 Turkey Market Artificial Intelligence Drug R&D Forecast
10.6 Global Artificial Intelligence Drug R&D Forecast by Type (2027-2032)
10.7 Global Artificial Intelligence Drug R&D Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Artificial Intelligence Drug R&D Forecast
11 KEY PLAYERS ANALYSIS
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Information
11.1.2 Insilico Medicine Artificial Intelligence Drug R&D Product Offered
11.1.3 Insilico Medicine Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Insilico Medicine Main Business Overview
11.1.5 Insilico Medicine Latest Developments
11.2 Recursion
11.2.1 Recursion Company Information
11.2.2 Recursion Artificial Intelligence Drug R&D Product Offered
11.2.3 Recursion Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Recursion Main Business Overview
11.2.5 Recursion Latest Developments
11.3 BenevolentAI
11.3.1 BenevolentAI Company Information
11.3.2 BenevolentAI Artificial Intelligence Drug R&D Product Offered
11.3.3 BenevolentAI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 BenevolentAI Main Business Overview
11.3.5 BenevolentAI Latest Developments
11.4 Atomwise
11.4.1 Atomwise Company Information
11.4.2 Atomwise Artificial Intelligence Drug R&D Product Offered
11.4.3 Atomwise Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Atomwise Main Business Overview
11.4.5 Atomwise Latest Developments
11.5 Recursion Pharmaceuticals
11.5.1 Recursion Pharmaceuticals Company Information
11.5.2 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product Offered
11.5.3 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Recursion Pharmaceuticals Main Business Overview
11.5.5 Recursion Pharmaceuticals Latest Developments
11.6 DeepMind?Google?
11.6.1 DeepMind?Google? Company Information
11.6.2 DeepMind?Google? Artificial Intelligence Drug R&D Product Offered
11.6.3 DeepMind?Google? Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 DeepMind?Google? Main Business Overview
11.6.5 DeepMind?Google? Latest Developments
11.7 Insitro
11.7.1 Insitro Company Information
11.7.2 Insitro Artificial Intelligence Drug R&D Product Offered
11.7.3 Insitro Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Insitro Main Business Overview
11.7.5 Insitro Latest Developments
11.8 Owkin
11.8.1 Owkin Company Information
11.8.2 Owkin Artificial Intelligence Drug R&D Product Offered
11.8.3 Owkin Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Owkin Main Business Overview
11.8.5 Owkin Latest Developments
11.9 XtalPi
11.9.1 XtalPi Company Information
11.9.2 XtalPi Artificial Intelligence Drug R&D Product Offered
11.9.3 XtalPi Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 XtalPi Main Business Overview
11.9.5 XtalPi Latest Developments
11.10 Verge Genomics
11.10.1 Verge Genomics Company Information
11.10.2 Verge Genomics Artificial Intelligence Drug R&D Product Offered
11.10.3 Verge Genomics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Verge Genomics Main Business Overview
11.10.5 Verge Genomics Latest Developments
11.11 Iktos
11.11.1 Iktos Company Information
11.11.2 Iktos Artificial Intelligence Drug R&D Product Offered
11.11.3 Iktos Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Iktos Main Business Overview
11.11.5 Iktos Latest Developments
11.12 Valo Health
11.12.1 Valo Health Company Information
11.12.2 Valo Health Artificial Intelligence Drug R&D Product Offered
11.12.3 Valo Health Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Valo Health Main Business Overview
11.12.5 Valo Health Latest Developments
11.13 Standigm
11.13.1 Standigm Company Information
11.13.2 Standigm Artificial Intelligence Drug R&D Product Offered
11.13.3 Standigm Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Standigm Main Business Overview
11.13.5 Standigm Latest Developments
11.14 Relay Therapeutics
11.14.1 Relay Therapeutics Company Information
11.14.2 Relay Therapeutics Artificial Intelligence Drug R&D Product Offered
11.14.3 Relay Therapeutics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Relay Therapeutics Main Business Overview
11.14.5 Relay Therapeutics Latest Developments
11.15 Cyclica
11.15.1 Cyclica Company Information
11.15.2 Cyclica Artificial Intelligence Drug R&D Product Offered
11.15.3 Cyclica Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Cyclica Main Business Overview
11.15.5 Cyclica Latest Developments
11.16 Isomorphic Labs
11.16.1 Isomorphic Labs Company Information
11.16.2 Isomorphic Labs Artificial Intelligence Drug R&D Product Offered
11.16.3 Isomorphic Labs Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Isomorphic Labs Main Business Overview
11.16.5 Isomorphic Labs Latest Developments
11.17 Schr?dinger
11.17.1 Schr?dinger Company Information
11.17.2 Schr?dinger Artificial Intelligence Drug R&D Product Offered
11.17.3 Schr?dinger Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Schr?dinger Main Business Overview
11.17.5 Schr?dinger Latest Developments
11.18 Absci
11.18.1 Absci Company Information
11.18.2 Absci Artificial Intelligence Drug R&D Product Offered
11.18.3 Absci Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Absci Main Business Overview
11.18.5 Absci Latest Developments
11.19 Genesis Therapeutics
11.19.1 Genesis Therapeutics Company Information
11.19.2 Genesis Therapeutics Artificial Intelligence Drug R&D Product Offered
11.19.3 Genesis Therapeutics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Genesis Therapeutics Main Business Overview
11.19.5 Genesis Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Intelligence Drug R&D Market Size (2021-2032)
2.1.2 Artificial Intelligence Drug R&D Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Artificial Intelligence Drug R&D by Country/Region (2021, 2025 & 2032)
2.2 Artificial Intelligence Drug R&D Segment by Type
2.2.1 Software
2.2.2 Service
2.2.3 Artificial Intelligence Drug R&D Market Size by Type
2.2.3.1 Artificial Intelligence Drug R&D Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
2.3 Artificial Intelligence Drug R&D Segment by Stage
2.3.1 Target Identification & Validation
2.3.2 Hit/Lead Discovery
2.3.3 Clinical Development & Trial Design
2.3.4 Others
2.3.5 Artificial Intelligence Drug R&D Market Size by Stage
2.3.5.1 Artificial Intelligence Drug R&D Market Size CAGR by Stage (2021 VS 2025 VS 2032)
2.3.5.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Stage (2021-2026)
2.4 Artificial Intelligence Drug R&D Segment by Technology
2.4.1 Machine Learning & Deep Learning
2.4.2 Generative Models
2.4.3 Knowledge Graph & NLP
2.4.4 Multi-omics / Multimodal Modeling
2.4.5 Artificial Intelligence Drug R&D Market Size by Technology
2.4.5.1 Artificial Intelligence Drug R&D Market Size CAGR by Technology (2021 VS 2025 VS 2032)
2.4.5.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Technology (2021-2026)
2.5 Artificial Intelligence Drug R&D Segment by Application
2.5.1 Pharmaceutical Companies
2.5.2 Biotechnology Companies
2.5.3 Contract Research Organizations?CRO)
2.5.4 Academic & Research Institutions
2.5.5 Others
2.5.6 Artificial Intelligence Drug R&D Market Size by Application
2.5.6.1 Artificial Intelligence Drug R&D Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.6.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)
3 ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE BY PLAYER
3.1 Artificial Intelligence Drug R&D Market Size Market Share by Player
3.1.1 Global Artificial Intelligence Drug R&D Revenue by Player (2021-2026)
3.1.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Player (2021-2026)
3.2 Global Artificial Intelligence Drug R&D Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ARTIFICIAL INTELLIGENCE DRUG R&D BY REGION
4.1 Artificial Intelligence Drug R&D Market Size by Region (2021-2026)
4.2 Global Artificial Intelligence Drug R&D Annual Revenue by Country/Region (2021-2026)
4.3 Americas Artificial Intelligence Drug R&D Market Size Growth (2021-2026)
4.4 APAC Artificial Intelligence Drug R&D Market Size Growth (2021-2026)
4.5 Europe Artificial Intelligence Drug R&D Market Size Growth (2021-2026)
4.6 Middle East & Africa Artificial Intelligence Drug R&D Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Artificial Intelligence Drug R&D Market Size by Country (2021-2026)
5.2 Americas Artificial Intelligence Drug R&D Market Size by Type (2021-2026)
5.3 Americas Artificial Intelligence Drug R&D Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence Drug R&D Market Size by Region (2021-2026)
6.2 APAC Artificial Intelligence Drug R&D Market Size by Type (2021-2026)
6.3 APAC Artificial Intelligence Drug R&D Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Artificial Intelligence Drug R&D Market Size by Country (2021-2026)
7.2 Europe Artificial Intelligence Drug R&D Market Size by Type (2021-2026)
7.3 Europe Artificial Intelligence Drug R&D Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Intelligence Drug R&D by Region (2021-2026)
8.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2021-2026)
8.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ARTIFICIAL INTELLIGENCE DRUG R&D MARKET FORECAST
10.1 Global Artificial Intelligence Drug R&D Forecast by Region (2027-2032)
10.1.1 Global Artificial Intelligence Drug R&D Forecast by Region (2027-2032)
10.1.2 Americas Artificial Intelligence Drug R&D Forecast
10.1.3 APAC Artificial Intelligence Drug R&D Forecast
10.1.4 Europe Artificial Intelligence Drug R&D Forecast
10.1.5 Middle East & Africa Artificial Intelligence Drug R&D Forecast
10.2 Americas Artificial Intelligence Drug R&D Forecast by Country (2027-2032)
10.2.1 United States Market Artificial Intelligence Drug R&D Forecast
10.2.2 Canada Market Artificial Intelligence Drug R&D Forecast
10.2.3 Mexico Market Artificial Intelligence Drug R&D Forecast
10.2.4 Brazil Market Artificial Intelligence Drug R&D Forecast
10.3 APAC Artificial Intelligence Drug R&D Forecast by Region (2027-2032)
10.3.1 China Artificial Intelligence Drug R&D Market Forecast
10.3.2 Japan Market Artificial Intelligence Drug R&D Forecast
10.3.3 Korea Market Artificial Intelligence Drug R&D Forecast
10.3.4 Southeast Asia Market Artificial Intelligence Drug R&D Forecast
10.3.5 India Market Artificial Intelligence Drug R&D Forecast
10.3.6 Australia Market Artificial Intelligence Drug R&D Forecast
10.4 Europe Artificial Intelligence Drug R&D Forecast by Country (2027-2032)
10.4.1 Germany Market Artificial Intelligence Drug R&D Forecast
10.4.2 France Market Artificial Intelligence Drug R&D Forecast
10.4.3 UK Market Artificial Intelligence Drug R&D Forecast
10.4.4 Italy Market Artificial Intelligence Drug R&D Forecast
10.4.5 Russia Market Artificial Intelligence Drug R&D Forecast
10.5 Middle East & Africa Artificial Intelligence Drug R&D Forecast by Region (2027-2032)
10.5.1 Egypt Market Artificial Intelligence Drug R&D Forecast
10.5.2 South Africa Market Artificial Intelligence Drug R&D Forecast
10.5.3 Israel Market Artificial Intelligence Drug R&D Forecast
10.5.4 Turkey Market Artificial Intelligence Drug R&D Forecast
10.6 Global Artificial Intelligence Drug R&D Forecast by Type (2027-2032)
10.7 Global Artificial Intelligence Drug R&D Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Artificial Intelligence Drug R&D Forecast
11 KEY PLAYERS ANALYSIS
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Information
11.1.2 Insilico Medicine Artificial Intelligence Drug R&D Product Offered
11.1.3 Insilico Medicine Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Insilico Medicine Main Business Overview
11.1.5 Insilico Medicine Latest Developments
11.2 Recursion
11.2.1 Recursion Company Information
11.2.2 Recursion Artificial Intelligence Drug R&D Product Offered
11.2.3 Recursion Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Recursion Main Business Overview
11.2.5 Recursion Latest Developments
11.3 BenevolentAI
11.3.1 BenevolentAI Company Information
11.3.2 BenevolentAI Artificial Intelligence Drug R&D Product Offered
11.3.3 BenevolentAI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 BenevolentAI Main Business Overview
11.3.5 BenevolentAI Latest Developments
11.4 Atomwise
11.4.1 Atomwise Company Information
11.4.2 Atomwise Artificial Intelligence Drug R&D Product Offered
11.4.3 Atomwise Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Atomwise Main Business Overview
11.4.5 Atomwise Latest Developments
11.5 Recursion Pharmaceuticals
11.5.1 Recursion Pharmaceuticals Company Information
11.5.2 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product Offered
11.5.3 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Recursion Pharmaceuticals Main Business Overview
11.5.5 Recursion Pharmaceuticals Latest Developments
11.6 DeepMind?Google?
11.6.1 DeepMind?Google? Company Information
11.6.2 DeepMind?Google? Artificial Intelligence Drug R&D Product Offered
11.6.3 DeepMind?Google? Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 DeepMind?Google? Main Business Overview
11.6.5 DeepMind?Google? Latest Developments
11.7 Insitro
11.7.1 Insitro Company Information
11.7.2 Insitro Artificial Intelligence Drug R&D Product Offered
11.7.3 Insitro Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Insitro Main Business Overview
11.7.5 Insitro Latest Developments
11.8 Owkin
11.8.1 Owkin Company Information
11.8.2 Owkin Artificial Intelligence Drug R&D Product Offered
11.8.3 Owkin Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Owkin Main Business Overview
11.8.5 Owkin Latest Developments
11.9 XtalPi
11.9.1 XtalPi Company Information
11.9.2 XtalPi Artificial Intelligence Drug R&D Product Offered
11.9.3 XtalPi Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 XtalPi Main Business Overview
11.9.5 XtalPi Latest Developments
11.10 Verge Genomics
11.10.1 Verge Genomics Company Information
11.10.2 Verge Genomics Artificial Intelligence Drug R&D Product Offered
11.10.3 Verge Genomics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Verge Genomics Main Business Overview
11.10.5 Verge Genomics Latest Developments
11.11 Iktos
11.11.1 Iktos Company Information
11.11.2 Iktos Artificial Intelligence Drug R&D Product Offered
11.11.3 Iktos Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Iktos Main Business Overview
11.11.5 Iktos Latest Developments
11.12 Valo Health
11.12.1 Valo Health Company Information
11.12.2 Valo Health Artificial Intelligence Drug R&D Product Offered
11.12.3 Valo Health Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Valo Health Main Business Overview
11.12.5 Valo Health Latest Developments
11.13 Standigm
11.13.1 Standigm Company Information
11.13.2 Standigm Artificial Intelligence Drug R&D Product Offered
11.13.3 Standigm Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Standigm Main Business Overview
11.13.5 Standigm Latest Developments
11.14 Relay Therapeutics
11.14.1 Relay Therapeutics Company Information
11.14.2 Relay Therapeutics Artificial Intelligence Drug R&D Product Offered
11.14.3 Relay Therapeutics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Relay Therapeutics Main Business Overview
11.14.5 Relay Therapeutics Latest Developments
11.15 Cyclica
11.15.1 Cyclica Company Information
11.15.2 Cyclica Artificial Intelligence Drug R&D Product Offered
11.15.3 Cyclica Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Cyclica Main Business Overview
11.15.5 Cyclica Latest Developments
11.16 Isomorphic Labs
11.16.1 Isomorphic Labs Company Information
11.16.2 Isomorphic Labs Artificial Intelligence Drug R&D Product Offered
11.16.3 Isomorphic Labs Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Isomorphic Labs Main Business Overview
11.16.5 Isomorphic Labs Latest Developments
11.17 Schr?dinger
11.17.1 Schr?dinger Company Information
11.17.2 Schr?dinger Artificial Intelligence Drug R&D Product Offered
11.17.3 Schr?dinger Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Schr?dinger Main Business Overview
11.17.5 Schr?dinger Latest Developments
11.18 Absci
11.18.1 Absci Company Information
11.18.2 Absci Artificial Intelligence Drug R&D Product Offered
11.18.3 Absci Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Absci Main Business Overview
11.18.5 Absci Latest Developments
11.19 Genesis Therapeutics
11.19.1 Genesis Therapeutics Company Information
11.19.2 Genesis Therapeutics Artificial Intelligence Drug R&D Product Offered
11.19.3 Genesis Therapeutics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Genesis Therapeutics Main Business Overview
11.19.5 Genesis Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Artificial Intelligence Drug R&D Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Artificial Intelligence Drug R&D Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Software
Table 4. Major Players of Service
Table 5. Artificial Intelligence Drug R&D Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Artificial Intelligence Drug R&D Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Target Identification & Validation
Table 9. Major Players of Hit/Lead Discovery
Table 10. Major Players of Clinical Development & Trial Design
Table 11. Major Players of Others
Table 12. Artificial Intelligence Drug R&D Market Size CAGR by Stage (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Artificial Intelligence Drug R&D Market Size by Stage (2021-2026) & ($ millions)
Table 14. Global Artificial Intelligence Drug R&D Market Size Market Share by Stage (2021-2026)
Table 15. Major Players of Machine Learning & Deep Learning
Table 16. Major Players of Generative Models
Table 17. Major Players of Knowledge Graph & NLP
Table 18. Major Players of Multi-omics / Multimodal Modeling
Table 19. Artificial Intelligence Drug R&D Market Size CAGR by Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Artificial Intelligence Drug R&D Market Size by Technology (2021-2026) & ($ millions)
Table 21. Global Artificial Intelligence Drug R&D Market Size Market Share by Technology (2021-2026)
Table 22. Artificial Intelligence Drug R&D Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Artificial Intelligence Drug R&D Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)
Table 25. Global Artificial Intelligence Drug R&D Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Artificial Intelligence Drug R&D Revenue Market Share by Player (2021-2026)
Table 27. Artificial Intelligence Drug R&D Key Players Head office and Products Offered
Table 28. Artificial Intelligence Drug R&D Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Artificial Intelligence Drug R&D Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Artificial Intelligence Drug R&D Market Size Market Share by Region (2021-2026)
Table 33. Global Artificial Intelligence Drug R&D Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Artificial Intelligence Drug R&D Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Artificial Intelligence Drug R&D Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Artificial Intelligence Drug R&D Market Size Market Share by Country (2021-2026)
Table 37. Americas Artificial Intelligence Drug R&D Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
Table 39. Americas Artificial Intelligence Drug R&D Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)
Table 41. APAC Artificial Intelligence Drug R&D Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Artificial Intelligence Drug R&D Market Size Market Share by Region (2021-2026)
Table 43. APAC Artificial Intelligence Drug R&D Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Artificial Intelligence Drug R&D Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Artificial Intelligence Drug R&D Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Artificial Intelligence Drug R&D Market Size Market Share by Country (2021-2026)
Table 47. Europe Artificial Intelligence Drug R&D Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Artificial Intelligence Drug R&D Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Artificial Intelligence Drug R&D
Table 53. Key Market Challenges & Risks of Artificial Intelligence Drug R&D
Table 54. Key Industry Trends of Artificial Intelligence Drug R&D
Table 55. Global Artificial Intelligence Drug R&D Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Artificial Intelligence Drug R&D Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Artificial Intelligence Drug R&D Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. Insilico Medicine Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 60. Insilico Medicine Artificial Intelligence Drug R&D Product Offered
Table 61. Insilico Medicine Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Insilico Medicine Main Business
Table 63. Insilico Medicine Latest Developments
Table 64. Recursion Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 65. Recursion Artificial Intelligence Drug R&D Product Offered
Table 66. Recursion Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Recursion Main Business
Table 68. Recursion Latest Developments
Table 69. BenevolentAI Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 70. BenevolentAI Artificial Intelligence Drug R&D Product Offered
Table 71. BenevolentAI Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. BenevolentAI Main Business
Table 73. BenevolentAI Latest Developments
Table 74. Atomwise Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 75. Atomwise Artificial Intelligence Drug R&D Product Offered
Table 76. Atomwise Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Atomwise Main Business
Table 78. Atomwise Latest Developments
Table 79. Recursion Pharmaceuticals Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 80. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product Offered
Table 81. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Recursion Pharmaceuticals Main Business
Table 83. Recursion Pharmaceuticals Latest Developments
Table 84. DeepMind?Google? Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 85. DeepMind?Google? Artificial Intelligence Drug R&D Product Offered
Table 86. DeepMind?Google? Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. DeepMind?Google? Main Business
Table 88. DeepMind?Google? Latest Developments
Table 89. Insitro Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 90. Insitro Artificial Intelligence Drug R&D Product Offered
Table 91. Insitro Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Insitro Main Business
Table 93. Insitro Latest Developments
Table 94. Owkin Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 95. Owkin Artificial Intelligence Drug R&D Product Offered
Table 96. Owkin Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Owkin Main Business
Table 98. Owkin Latest Developments
Table 99. XtalPi Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 100. XtalPi Artificial Intelligence Drug R&D Product Offered
Table 101. XtalPi Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. XtalPi Main Business
Table 103. XtalPi Latest Developments
Table 104. Verge Genomics Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 105. Verge Genomics Artificial Intelligence Drug R&D Product Offered
Table 106. Verge Genomics Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Verge Genomics Main Business
Table 108. Verge Genomics Latest Developments
Table 109. Iktos Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 110. Iktos Artificial Intelligence Drug R&D Product Offered
Table 111. Iktos Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Iktos Main Business
Table 113. Iktos Latest Developments
Table 114. Valo Health Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 115. Valo Health Artificial Intelligence Drug R&D Product Offered
Table 116. Valo Health Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Valo Health Main Business
Table 118. Valo Health Latest Developments
Table 119. Standigm Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 120. Standigm Artificial Intelligence Drug R&D Product Offered
Table 121. Standigm Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Standigm Main Business
Table 123. Standigm Latest Developments
Table 124. Relay Therapeutics Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 125. Relay Therapeutics Artificial Intelligence Drug R&D Product Offered
Table 126. Relay Therapeutics Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Relay Therapeutics Main Business
Table 128. Relay Therapeutics Latest Developments
Table 129. Cyclica Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 130. Cyclica Artificial Intelligence Drug R&D Product Offered
Table 131. Cyclica Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Cyclica Main Business
Table 133. Cyclica Latest Developments
Table 134. Isomorphic Labs Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 135. Isomorphic Labs Artificial Intelligence Drug R&D Product Offered
Table 136. Isomorphic Labs Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Isomorphic Labs Main Business
Table 138. Isomorphic Labs Latest Developments
Table 139. Schr?dinger Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 140. Schr?dinger Artificial Intelligence Drug R&D Product Offered
Table 141. Schr?dinger Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. Schr?dinger Main Business
Table 143. Schr?dinger Latest Developments
Table 144. Absci Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 145. Absci Artificial Intelligence Drug R&D Product Offered
Table 146. Absci Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 147. Absci Main Business
Table 148. Absci Latest Developments
Table 149. Genesis Therapeutics Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 150. Genesis Therapeutics Artificial Intelligence Drug R&D Product Offered
Table 151. Genesis Therapeutics Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 152. Genesis Therapeutics Main Business
Table 153. Genesis Therapeutics Latest Developments
Table 1. Artificial Intelligence Drug R&D Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Artificial Intelligence Drug R&D Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Software
Table 4. Major Players of Service
Table 5. Artificial Intelligence Drug R&D Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Artificial Intelligence Drug R&D Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Target Identification & Validation
Table 9. Major Players of Hit/Lead Discovery
Table 10. Major Players of Clinical Development & Trial Design
Table 11. Major Players of Others
Table 12. Artificial Intelligence Drug R&D Market Size CAGR by Stage (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Artificial Intelligence Drug R&D Market Size by Stage (2021-2026) & ($ millions)
Table 14. Global Artificial Intelligence Drug R&D Market Size Market Share by Stage (2021-2026)
Table 15. Major Players of Machine Learning & Deep Learning
Table 16. Major Players of Generative Models
Table 17. Major Players of Knowledge Graph & NLP
Table 18. Major Players of Multi-omics / Multimodal Modeling
Table 19. Artificial Intelligence Drug R&D Market Size CAGR by Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Artificial Intelligence Drug R&D Market Size by Technology (2021-2026) & ($ millions)
Table 21. Global Artificial Intelligence Drug R&D Market Size Market Share by Technology (2021-2026)
Table 22. Artificial Intelligence Drug R&D Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Artificial Intelligence Drug R&D Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)
Table 25. Global Artificial Intelligence Drug R&D Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Artificial Intelligence Drug R&D Revenue Market Share by Player (2021-2026)
Table 27. Artificial Intelligence Drug R&D Key Players Head office and Products Offered
Table 28. Artificial Intelligence Drug R&D Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Artificial Intelligence Drug R&D Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Artificial Intelligence Drug R&D Market Size Market Share by Region (2021-2026)
Table 33. Global Artificial Intelligence Drug R&D Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Artificial Intelligence Drug R&D Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Artificial Intelligence Drug R&D Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Artificial Intelligence Drug R&D Market Size Market Share by Country (2021-2026)
Table 37. Americas Artificial Intelligence Drug R&D Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
Table 39. Americas Artificial Intelligence Drug R&D Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)
Table 41. APAC Artificial Intelligence Drug R&D Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Artificial Intelligence Drug R&D Market Size Market Share by Region (2021-2026)
Table 43. APAC Artificial Intelligence Drug R&D Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Artificial Intelligence Drug R&D Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Artificial Intelligence Drug R&D Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Artificial Intelligence Drug R&D Market Size Market Share by Country (2021-2026)
Table 47. Europe Artificial Intelligence Drug R&D Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Artificial Intelligence Drug R&D Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Artificial Intelligence Drug R&D
Table 53. Key Market Challenges & Risks of Artificial Intelligence Drug R&D
Table 54. Key Industry Trends of Artificial Intelligence Drug R&D
Table 55. Global Artificial Intelligence Drug R&D Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Artificial Intelligence Drug R&D Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Artificial Intelligence Drug R&D Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. Insilico Medicine Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 60. Insilico Medicine Artificial Intelligence Drug R&D Product Offered
Table 61. Insilico Medicine Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Insilico Medicine Main Business
Table 63. Insilico Medicine Latest Developments
Table 64. Recursion Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 65. Recursion Artificial Intelligence Drug R&D Product Offered
Table 66. Recursion Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Recursion Main Business
Table 68. Recursion Latest Developments
Table 69. BenevolentAI Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 70. BenevolentAI Artificial Intelligence Drug R&D Product Offered
Table 71. BenevolentAI Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. BenevolentAI Main Business
Table 73. BenevolentAI Latest Developments
Table 74. Atomwise Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 75. Atomwise Artificial Intelligence Drug R&D Product Offered
Table 76. Atomwise Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Atomwise Main Business
Table 78. Atomwise Latest Developments
Table 79. Recursion Pharmaceuticals Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 80. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product Offered
Table 81. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Recursion Pharmaceuticals Main Business
Table 83. Recursion Pharmaceuticals Latest Developments
Table 84. DeepMind?Google? Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 85. DeepMind?Google? Artificial Intelligence Drug R&D Product Offered
Table 86. DeepMind?Google? Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. DeepMind?Google? Main Business
Table 88. DeepMind?Google? Latest Developments
Table 89. Insitro Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 90. Insitro Artificial Intelligence Drug R&D Product Offered
Table 91. Insitro Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Insitro Main Business
Table 93. Insitro Latest Developments
Table 94. Owkin Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 95. Owkin Artificial Intelligence Drug R&D Product Offered
Table 96. Owkin Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Owkin Main Business
Table 98. Owkin Latest Developments
Table 99. XtalPi Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 100. XtalPi Artificial Intelligence Drug R&D Product Offered
Table 101. XtalPi Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. XtalPi Main Business
Table 103. XtalPi Latest Developments
Table 104. Verge Genomics Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 105. Verge Genomics Artificial Intelligence Drug R&D Product Offered
Table 106. Verge Genomics Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Verge Genomics Main Business
Table 108. Verge Genomics Latest Developments
Table 109. Iktos Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 110. Iktos Artificial Intelligence Drug R&D Product Offered
Table 111. Iktos Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Iktos Main Business
Table 113. Iktos Latest Developments
Table 114. Valo Health Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 115. Valo Health Artificial Intelligence Drug R&D Product Offered
Table 116. Valo Health Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Valo Health Main Business
Table 118. Valo Health Latest Developments
Table 119. Standigm Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 120. Standigm Artificial Intelligence Drug R&D Product Offered
Table 121. Standigm Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Standigm Main Business
Table 123. Standigm Latest Developments
Table 124. Relay Therapeutics Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 125. Relay Therapeutics Artificial Intelligence Drug R&D Product Offered
Table 126. Relay Therapeutics Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Relay Therapeutics Main Business
Table 128. Relay Therapeutics Latest Developments
Table 129. Cyclica Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 130. Cyclica Artificial Intelligence Drug R&D Product Offered
Table 131. Cyclica Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Cyclica Main Business
Table 133. Cyclica Latest Developments
Table 134. Isomorphic Labs Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 135. Isomorphic Labs Artificial Intelligence Drug R&D Product Offered
Table 136. Isomorphic Labs Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Isomorphic Labs Main Business
Table 138. Isomorphic Labs Latest Developments
Table 139. Schr?dinger Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 140. Schr?dinger Artificial Intelligence Drug R&D Product Offered
Table 141. Schr?dinger Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. Schr?dinger Main Business
Table 143. Schr?dinger Latest Developments
Table 144. Absci Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 145. Absci Artificial Intelligence Drug R&D Product Offered
Table 146. Absci Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 147. Absci Main Business
Table 148. Absci Latest Developments
Table 149. Genesis Therapeutics Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 150. Genesis Therapeutics Artificial Intelligence Drug R&D Product Offered
Table 151. Genesis Therapeutics Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 152. Genesis Therapeutics Main Business
Table 153. Genesis Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Artificial Intelligence Drug R&D Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artificial Intelligence Drug R&D Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Artificial Intelligence Drug R&D Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Artificial Intelligence Drug R&D Sales Market Share by Country/Region (2025)
Figure 8. Artificial Intelligence Drug R&D Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Artificial Intelligence Drug R&D Market Size Market Share by Type in 2025
Figure 10. Global Artificial Intelligence Drug R&D Market Size Market Share by Stage in 2025
Figure 11. Global Artificial Intelligence Drug R&D Market Size Market Share by Technology in 2025
Figure 12. Artificial Intelligence Drug R&D in Pharmaceutical Companies
Figure 13. Global Artificial Intelligence Drug R&D Market: Pharmaceutical Companies (2021-2026) & ($ millions)
Figure 14. Artificial Intelligence Drug R&D in Biotechnology Companies
Figure 15. Global Artificial Intelligence Drug R&D Market: Biotechnology Companies (2021-2026) & ($ millions)
Figure 16. Artificial Intelligence Drug R&D in Contract Research Organizations?CRO)
Figure 17. Global Artificial Intelligence Drug R&D Market: Contract Research Organizations?CRO) (2021-2026) & ($ millions)
Figure 18. Artificial Intelligence Drug R&D in Academic & Research Institutions
Figure 19. Global Artificial Intelligence Drug R&D Market: Academic & Research Institutions (2021-2026) & ($ millions)
Figure 20. Artificial Intelligence Drug R&D in Others
Figure 21. Global Artificial Intelligence Drug R&D Market: Others (2021-2026) & ($ millions)
Figure 22. Global Artificial Intelligence Drug R&D Market Size Market Share by Application in 2025
Figure 23. Global Artificial Intelligence Drug R&D Revenue Market Share by Player in 2025
Figure 24. Global Artificial Intelligence Drug R&D Market Size Market Share by Region (2021-2026)
Figure 25. Americas Artificial Intelligence Drug R&D Market Size 2021-2026 ($ millions)
Figure 26. APAC Artificial Intelligence Drug R&D Market Size 2021-2026 ($ millions)
Figure 27. Europe Artificial Intelligence Drug R&D Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2021-2026 ($ millions)
Figure 29. Americas Artificial Intelligence Drug R&D Value Market Share by Country in 2025
Figure 30. United States Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Artificial Intelligence Drug R&D Market Size Market Share by Region in 2025
Figure 35. APAC Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
Figure 36. APAC Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)
Figure 37. China Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 41. India Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Artificial Intelligence Drug R&D Market Size Market Share by Country in 2025
Figure 44. Europe Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
Figure 45. Europe Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)
Figure 46. Germany Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 47. France Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 60. APAC Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 61. Europe Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 63. United States Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 64. Canada Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 65. Mexico Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 66. Brazil Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 67. China Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 68. Japan Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 69. Korea Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 71. India Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 72. Australia Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 73. Germany Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 74. France Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 75. UK Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 76. Italy Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 77. Russia Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 78. Egypt Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 79. South Africa Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 80. Israel Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 81. Turkey Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 82. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 1. Artificial Intelligence Drug R&D Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artificial Intelligence Drug R&D Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Artificial Intelligence Drug R&D Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Artificial Intelligence Drug R&D Sales Market Share by Country/Region (2025)
Figure 8. Artificial Intelligence Drug R&D Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Artificial Intelligence Drug R&D Market Size Market Share by Type in 2025
Figure 10. Global Artificial Intelligence Drug R&D Market Size Market Share by Stage in 2025
Figure 11. Global Artificial Intelligence Drug R&D Market Size Market Share by Technology in 2025
Figure 12. Artificial Intelligence Drug R&D in Pharmaceutical Companies
Figure 13. Global Artificial Intelligence Drug R&D Market: Pharmaceutical Companies (2021-2026) & ($ millions)
Figure 14. Artificial Intelligence Drug R&D in Biotechnology Companies
Figure 15. Global Artificial Intelligence Drug R&D Market: Biotechnology Companies (2021-2026) & ($ millions)
Figure 16. Artificial Intelligence Drug R&D in Contract Research Organizations?CRO)
Figure 17. Global Artificial Intelligence Drug R&D Market: Contract Research Organizations?CRO) (2021-2026) & ($ millions)
Figure 18. Artificial Intelligence Drug R&D in Academic & Research Institutions
Figure 19. Global Artificial Intelligence Drug R&D Market: Academic & Research Institutions (2021-2026) & ($ millions)
Figure 20. Artificial Intelligence Drug R&D in Others
Figure 21. Global Artificial Intelligence Drug R&D Market: Others (2021-2026) & ($ millions)
Figure 22. Global Artificial Intelligence Drug R&D Market Size Market Share by Application in 2025
Figure 23. Global Artificial Intelligence Drug R&D Revenue Market Share by Player in 2025
Figure 24. Global Artificial Intelligence Drug R&D Market Size Market Share by Region (2021-2026)
Figure 25. Americas Artificial Intelligence Drug R&D Market Size 2021-2026 ($ millions)
Figure 26. APAC Artificial Intelligence Drug R&D Market Size 2021-2026 ($ millions)
Figure 27. Europe Artificial Intelligence Drug R&D Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2021-2026 ($ millions)
Figure 29. Americas Artificial Intelligence Drug R&D Value Market Share by Country in 2025
Figure 30. United States Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Artificial Intelligence Drug R&D Market Size Market Share by Region in 2025
Figure 35. APAC Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
Figure 36. APAC Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)
Figure 37. China Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 41. India Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Artificial Intelligence Drug R&D Market Size Market Share by Country in 2025
Figure 44. Europe Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
Figure 45. Europe Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)
Figure 46. Germany Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 47. France Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Artificial Intelligence Drug R&D Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 60. APAC Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 61. Europe Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 63. United States Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 64. Canada Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 65. Mexico Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 66. Brazil Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 67. China Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 68. Japan Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 69. Korea Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 71. India Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 72. Australia Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 73. Germany Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 74. France Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 75. UK Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 76. Italy Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 77. Russia Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 78. Egypt Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 79. South Africa Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 80. Israel Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 81. Turkey Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
Figure 82. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Artificial Intelligence Drug R&D Market Size 2027-2032 ($ millions)
